Medically Reviewed & Authored by: George King
R&D Manager & Emergency Preparedness Specialist at Fitiger Life LLC.
When our engineering and product safety team looks at suction performance, we’re not chasing the biggest number on a gauge. We’re looking for controlled, repeatable suction that can matter in an emergency without creating unnecessary soft-tissue stress.
In our internal evaluation, we tested EasyPumpVac and FoldPumpVac through fixture-based bench work and supervised adult volunteer observations. Across the tested configurations and conditions described here, we observed a negative-pressure range of approximately 19 kPa to 42 kPa.
That range matters because suction in this category is a balancing act. Too little vacuum may not help with an obstruction. Poorly controlled loading at the higher end can create avoidable stress around the face, lips, mouth, or other soft tissues. The engineering question isn’t simply whether suction exists. It’s whether suction is controlled.
The problem with “strong suction” marketing
“Strong suction” may sound compelling in a headline. It doesn’t tell an engineer much.
When you design a rescue device, vacuum generation is a system variable. If vacuum is too low, the device may not generate enough force to help mobilize an obstruction. If tissue loading isn’t controlled, the same device may increase the risk of bruising or other superficial injury.
That’s why serious product development can’t stop at one headline number. Stroke length, sealing condition, repeatability, deployment behavior, and tissue-facing tolerance all matter.
That approach lines up with the concerns FDA has already highlighted for this category. In its March 2026 safety communication, FDA said reported problems with anti-choking devices included lack of suction, bruising around the face, lips, and mouth, and scratches in the back of the throat. FDA also emphasized that established choking rescue protocols should be used first, with anti-choking devices considered as a second option if standard protocols are unsuccessful.
We built our testing approach around that same tension: enough suction to matter, without ignoring secondary-injury risk.
How we actually test the hardware
We split our internal evaluation into two tracks: machine benchmarking and supervised adult-tolerance observation.
On the bench side, we mapped how the system behaved under different stroke lengths and sealing conditions. We looked at the highest and lowest negative pressures observed across those conditions because a rescue device can’t behave like a one-time demonstration. It needs repeatable, predictable output.
But fixtures don’t answer every question. Bench data can show how a device performs mechanically, but it can’t fully describe what the interface feels like when it’s placed against real skin and soft tissue. That’s where the volunteer portion matters.
In our supervised adult volunteer observations, we also looked at how the devices behaved under maximum-stroke conditions. Under the conditions described here, we did not observe injury in tested adults.
What we evaluated| What we evaluated | Why it mattered |
|---|---|
| Stroke travel limits | To map how vacuum changed from shorter travel to maximum stroke and to see how deployment behavior affected output. |
| Cycle-to-cycle repeatability | To confirm the device stayed within predictable pressure behavior across repeated use instead of acting like a one-off prototype. |
| Airway simulation | To capture cleaner baseline pressure data with sensors and fixtures before adding live-user variability. |
| Live tolerance observation | To assess whether higher vacuum conditions translated into visible superficial tissue stress during supervised adult observation. |
We didn’t build these devices as all-or-nothing plungers. The observed range of 19 kPa to 42 kPa helps characterize how the system behaves across different use conditions.
At the lower end, the range helps describe lower-output behavior under certain settings or partial strokes. At the higher end, it helps define the boundary that deserves closer review for both extraction intent and tissue-facing tolerance.
A single pressure number on a gauge doesn’t say much by itself. The more useful question is how that number relates to stroke length, seal integrity, deployment speed, and repeatability. That’s where the value of the range really sits. Not in the number alone, but in how it was studied as part of a broader reliability and safety program.
Bench testing and volunteer observation do different jobs, and both matter.
A fixture can show whether the system repeatedly produces a given vacuum band, whether output changes with stroke length, and whether sealing behavior remains stable. That’s essential for engineering characterization.
But a bench fixture can’t fully answer user-facing questions. It can’t tell you exactly how the interface behaves against the face, lips, or surrounding tissues under real contact conditions.
That’s why supervised adult observation is an important part of the overall picture. The goal isn’t to chase the biggest possible vacuum number. The goal is to confirm that suction can be delivered in a controlled way with an acceptable tolerance profile under the described conditions.
The public regulatory framework for this category matters, but it needs to be described carefully.
As of March 2026, FDA identifies “suction anti-choking device as a second-line treatment” under 21 CFR 874.5400 as a Class II device type. FDA’s March 2026 safety communication says established choking rescue protocols approved by the American Red Cross and the American Heart Association should be followed first, and that anti-choking devices may be used as a second option if standard protocols are unsuccessful.
That first-line versus second-line distinction matters. Public Red Cross guidance continues to emphasize combinations of back blows and abdominal thrusts for responsive adults and children during choking emergencies.
It’s also important to be precise about what FDA does not publicly say. FDA’s public materials describe the category and its safety concerns, but they do not publish one universal government-mandated kPa threshold for every suction anti-choking device. For that reason, this article does not treat 19–42 kPa as a stand-alone FDA authorization claim. We present that range as part of our internal engineering characterization work under the conditions described here.
These images and videos help make the testing process more concrete. Instead of relying on claims alone, they show the devices in a controlled measurement setup with fixture assemblies, instrument readouts, and live data capture.
The EasyPumpVac footage shows the plunger-style design mounted in the apparatus under test conditions. The FoldPumpVac footage shows the bellows-style design evaluated in the same kind of controlled setup. The volunteer footage matters for a different reason: it shows supervised adult observation with live pressure data visible on-screen while the device is being applied.
Figure 1. Bench setup for negative-pressure characterization of the device-mask interface and fixture-controlled vacuum generation.
Figure 2. Close-up fixture view showing face-form mount, mask seal, and device alignment during controlled negative-pressure testing.
Figure 3. Comparative bench arrangement showing FoldPumpVac and EasyPumpVac interfaces positioned for fixture-based evaluation.
Figure 4. Still frame from EasyPumpVac negative-pressure test video demonstrating live bench operation and instrument capture.
Figure 5. Still frame from FoldPumpVac negative-pressure test video showing foldable-device operation within the same measurement concept.
Figure 6. Still frame from controlled human-subject observation showing live pressure monitoring during adult tolerance evaluation.
We were not chasing the highest vacuum number in isolation.
We focused on repeatable negative pressure and tissue-facing tolerance together.
We tested different stroke lengths and conditions because real use is not one idealized pull.
We included volunteer observations because bench fixtures do not fully answer human-interface questions.
We kept the device’s second-line role in view, since real choking response still begins with established first-line protocols.
Schools, facility managers, and parents shouldn’t have to make emergency-readiness decisions based on vague claims about “power.”
What matters more is whether the device has been tested systematically, whether the suction range has been measured, whether the product has been evaluated across different conditions, and whether the development team has taken tissue-facing tolerance seriously.
That’s why documentation matters. Images of the EasyPumpVac mounted in a test fixture, the FoldPumpVac under controlled compression, and live pressure curves on-screen do more than make the process look technical. They help show that the hardware was evaluated through a structured measurement workflow instead of leaning only on anecdotal storytelling.
When airway access is compromised, controlled reliability matters more than dramatic language.
Conclusion
EasyPumpVac and FoldPumpVac were built to do more than generate suction. In our testing, we looked at how suction behaved across different stroke lengths and conditions, and we paired bench measurements with supervised adult volunteer observations. We observed negative-pressure values ranging from approximately 19 kPa to 42 kPa, with no injury observed at maximum stroke under the described conditions. For us, that is the point of this kind of testing: not chasing a bigger number, but understanding how the device behaves when control, consistency, and tissue-facing tolerance all matter.
What pressure range did our engineers observe during testing?
In our internal testing across different configurations, we observed a negative-pressure range of approximately 19 kPa to 42 kPa.
Is this only lab data?
No. We paired machine / fixture-based testing with supervised adult volunteer observations.
Did FDA mandate the 19–42 kPa range?
No. FDA’s public materials do not set one universal public pressure limit for every device in this category. We use this range here as internal characterization data, not as a stand-alone FDA authorization claim.
When should this kind of device be used?
FDA’s public safety communication says established choking rescue protocols should be used first, and anti-choking devices may be used as a second option if standard protocols are unsuccessful. Red Cross public guidance continues to emphasize back blows and abdominal thrusts for responsive adults and children.
This article is for engineering, educational, and preparedness purposes only. It does not replace professional medical advice, certified first-aid training, emergency dispatcher instructions, or product-specific regulatory review. First-line choking rescue protocols from recognized first-aid organizations should be followed first. Discussion of internal pressure measurements in this article should not be interpreted as a stand-alone FDA clearance or authorization claim.
1. U.S. Food and Drug Administration (FDA) — Safety communication on established choking rescue protocols, second-option device use, and reported category risks.
2. U.S. Food and Drug Administration (FDA) — De Novo classification record for suction anti-choking devices as second-line treatment under 21 CFR 874.5400.
3. American Red Cross — Public first-aid guidance for adult and child choking response, including back blows and abdominal thrusts.
4. Fitiger internal media
